Ensuring Access And Approval For Innovative Therapies In Scleroderma
Clinical research and development programs for innovative therapies in scleroderma must accommodate the diverse data needs of multiple stakeholders.
Stay updated with breaking news from Michaelf Murphy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Clinical research and development programs for innovative therapies in scleroderma must accommodate the diverse data needs of multiple stakeholders.
The regulatory, operational, and commercial forces that impact gene therapy development continue to evolve dramatically – not just in the US...
This paper examines ways in which the approach to feasibility in rare, geographically dispersed populations has evolved, with particular attention to...
Master protocols are created with hypothesis generation intentions to serve as a method to evaluate product utility across a portfolio of indications...
09/15/21 Clinical Leader Newsletter